Time to response for duloxetine 60 mg once daily versus placebo in elderly patients with major depressive disorderRASKIN, Joel; XU, Jimmy Y; KAJDASZ, Daniel K et al.International psychogeriatrics. 2008, Vol 20, Num 2, pp 309-327, issn 1041-6102, 19 p.Article

A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorderPERAHIA, David G. S; PRITCHETT, Yili Lu; THASE, Michael E et al.Journal of psychiatric research. 2008, Vol 42, Num 1, pp 22-34, issn 0022-3956, 13 p.Article

Efficacy of Duloxetine on cognition, depression, and pain in elderly Patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trialRASKIN, Joel; WILTSE, Curtis G; SIEGAL, Alan et al.The American journal of psychiatry. 2007, Vol 164, Num 6, issn 0002-953X, 900-902, 905-911 [10 p.]Article

Once-daily duloxetine 60 mg in the treatment of major depressive disorder : Multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and BrazilLEE, Phil; LIANG SHU; HARRISON, Gavan A et al.Psychiatry and clinical neurosciences (Carlton. Print). 2007, Vol 61, Num 3, pp 295-307, issn 1323-1316, 13 p.Article

Duloxetine in the long-term management of diabetic peripheral neuropathic pain : An open-label, 52-week extension of a randomized controlled clinical trialWERNICKE, Joachim F; RASKIN, Joel; ROSEN, Amy et al.Current therapeutic research. 2006, Vol 67, Num 5, pp 283-304, issn 0011-393X, 22 p.Article

Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: Outcomes following randomized switch to either duloxetine or escitalopramRASKIN, Joel; GEORGE, Thomas; GRANGER, Renee E et al.Journal of psychiatric research. 2012, Vol 46, Num 5, pp 667-674, issn 0022-3956, 8 p.Article

Safety and Tolerability of Duloxetine at 60 mg Once Daily in Elderly Patients With Major Depressive DisorderRASKIN, Joel; WILTSE, Curtis G; DINKEL, James J et al.Journal of clinical psychopharmacology. 2008, Vol 28, Num 1, pp 32-38, issn 0271-0749, 7 p.Article

An evaluation of the cardiovascular safety profile of duloxetine : Findings from 42 placebo-controlled studiesWERNICKE, Joachim; LLEDO, Alberto; RASKIN, Joel et al.Drug safety. 2007, Vol 30, Num 5, pp 437-455, issn 0114-5916, 19 p.Article

Incidence and duration ofantidepressant-induced nausea: Duloxetine compared with paroxetine and fluoxetineGREIST, John; MCNAMARA, Robert K; MALLINCKRODT, Craig H et al.Clinical therapeutics. 2004, Vol 26, Num 9, pp 1446-1455, issn 0149-2918, 10 p.Article

Duloxetine for the Treatment of Recurrent Major Depressive Disorder in Elderly Patients: Treatment Outcomes in Patients With Comorbid ArthritisWOHLREICH, Madelaine M; SULLIVAN, Mark D; MALLINCKRODT, Craig H et al.Psychosomatics (Washington, DC). 2009, Vol 50, Num 4, pp 402-412, issn 0033-3182, 11 p.Article

Duloxetine in the treatment of major depressive disorder : an assessment of the relationship between outcomes and episode characteristicsPERAHIA, David G. S; KAJDASZ, Daniel K; ROYER, Mary G et al.International clinical psychopharmacology. 2006, Vol 21, Num 5, pp 285-295, issn 0268-1315, 11 p.Article

Duloxetine in the long-term treatment of major depressive disorderRASKIN, Joel; GOLDSTEIN, David J; MALLINCKRODT, Craig H et al.The Journal of clinical psychiatry. 2003, Vol 64, Num 10, pp 1237-1244, issn 0160-6689, 8 p.Article

Rapid tranquilization with olanzapine in acute psychosis : A case seriesKARAGIANIS, James L; DAWE, Ian C; THAKUR, Aruna et al.The Journal of clinical psychiatry. Supplement. 2001, Vol 62, Num 2, pp 12-16Article

Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpointPOLLACK, Mark H; KORNSTEIN, Susan G; SPANN, Melissa E et al.Journal of psychiatric research. 2008, Vol 42, Num 14, pp 1176-1184, issn 0022-3956, 9 p.Article

Duloxetine treatment for role functioning improvement in generalized anxiety disorder : Three independent studiesENDICOTT, Jean; RUSSELL, James M; RASKIN, Joel et al.The Journal of clinical psychiatry. 2007, Vol 68, Num 4, pp 518-524, issn 0160-6689, 7 p.Article

Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology : A randomized controlled trialBRECHT, Stephan; COURTECUISSE, Christine; DEBIEUVRE, Catherine et al.The Journal of clinical psychiatry. 2007, Vol 68, Num 11, pp 1707-1716, issn 0160-6689, 10 p.Article

Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain = La Duloxetine en tant que traitement quotidien à long terme pour le traitement des douleurs neuropathiques chez les diabétiques]RASKIN, Joel; SMITH, Thimothy-R; WONG, Kar et al.JOURNAL OF PALLIATIVE MEDICINE. 2006, Vol 9, Num 1, pp 29-40, issn 1096-6218, 12 p.Article

Efficacy of duloxetine in painful symptoms : an analgesic or antidepressant effect?PERAHIA, David G. S; PRITCHETT, Yili L; DESAIAH, Durisala et al.International clinical psychopharmacology. 2006, Vol 21, Num 6, pp 311-317, issn 0268-1315, 7 p.Article

The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorderROTHSCHILD, Anthony J; RASKIN, Joel; WANG, Chia-Ning et al.Comprehensive psychiatry (Print). 2014, Vol 55, Num 1, pp 1-10, issn 0010-440X, 10 p.Article

Safety and tolerability of duloxetine in elderly patients with major depressive disorder: a pooled analysis of two placebo-controlled studiesOAKES, Tina M; KATONA, Cornelius; PENG LIU et al.International clinical psychopharmacology. 2013, Vol 28, Num 1, pp 1-11, issn 0268-1315, 11 p.Article

Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depressionSHELTON, Richard C; ANDORN, Anne C; MALLINCKRODT, Craig H et al.International clinical psychopharmacology. 2007, Vol 22, Num 6, pp 348-355, issn 0268-1315, 8 p.Article

Management of depression relapse : Re-initiation of duloxetine treatment or dose increaseFAVA, Maurizio; DETKE, Michael J; BALESTRIERI, Matteo et al.Journal of psychiatric research. 2006, Vol 40, Num 4, pp 328-336, issn 0022-3956, 9 p.Article

Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: A preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effectsKENNEDY, Sidney H; MCCANN, Sonia M; MASELLIS, Mario et al.The Journal of clinical psychiatry. 2002, Vol 63, Num 3, pp 181-186, issn 0160-6689Article